[1] Rutten FH, Cramer M-JM, Grobbee DE, Sachs APE, Kirkels JH, Lammers J-WJ, Hoes AW. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 2005;26:1887–1894.

[2] Boonman-de Winter LJM, Rutten FH, Cramer MJM, Landman MJ, Liem AH, Rutten EHM, Hoes AW. High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes. Diabetologia 2012;55:2154–2162.

[3] McKnee PA, Castelli WP, McNamara PM, Kannel WB: The natural history of congestive heart failure, The Framingham Study. N Engl J Med 1971; 285: 1441-1447.

[4] Wilhelmsen L, Erikson H, Svärdsudd K, Caidahl K: Improving the detection and diagnosis of congestive heart failure. Eur Heart J 1989; 10 (Supl C): 13-18 (Revisión).

[5] Cleland JG, Khand A, Clark A. The heart failure epidemic: exactly how big is it? Eur Heart J. 2001;22:623-6.

[6] Rodríguez-Artalejo F, Banegas JR, Guallar-Castillón P. Epidemiología de la insuficiencia cardíaca. Rev Esp Cardiol. 2004;57:163-70 (Revisión).

[7] MacMurray JJ, Stewart S. Heart failure: Epidemiology, etiology and prognosis of heart failure. Heart. 2000;83:596-602.

[8] van Riet EES, Hoes AW, Wagenaar KP, Limburg A, Landman MAJ, Rutten FH. Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review. Eur J Heart Fail 2016.

[9] Cowie MR, Mosterd A, Wood DA, Deckers JW, Poole-Wilson PA, Sutton GC, Grobbee DE: The epidemiology of heart failure. Eur Heart J, 1997; 18: 208-225 (Revisión).

[10] Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007;93: 1137–1146.

[11] Anguita Sánchez M, Crespo Leiro MG, de Teresa Galván E, Jiménez Navarro M, Alonso-Pulpón L,Muñiz García J on behalf of the PRICE study investigators Prevalence of Heart Failure in the Spanish General Population Aged Over 45 Years. The PRICE Study. Rev Esp Cardiol 2008; 61: 1041-9.

[12] Kannel WB, Castelli WP, McNamara PM, McKee PA, Feinleib M: Role of blood pressure in the development of congestive heart failure. The Framingham Study. N Engl J Med 1972; 287: 781-7.

[13] Systolic Hypertension in the Elderly Program cooperative research group. Implications of the Systolic Hypertension in the Elderly Program. Hypertension 1993; 21: 335-43 (Ensayo Clínico).

[14] Dahlöf B, Lindholm LH, Hansson L et al: Morbidity and mortality in the Swedish Trial of Old Presons with Hypertension. Lancet 1991; 338: 1281-5) (Ensayo Clínico).

[15] Ho KKL, Anderson KM, Kannel WB, Grossman W, Levy D: Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993; 88: 107-115.

[16] Mann DL. Pathophysiology of Heart Failure. En Braunwald E: Heart Disease (8ª edición). Saunders Elsevier, Philadelphia, 2008 (Revisión).

[17] Cosin J, Cruz Fernández JM, de Teresa Galván E, Ferreira Montero I, López-Sendón Jl, Soler Soler J, Tamargo Menéndez J: Factores neurohormonales en la insuficiencia cardiaca (I, II y III). Rev Esp Cardiol 1996; 49: 239-252, 317-327 y 405-422 (Revisión).

[18] Redfield MM. Heart Failure with Normal Ejection Fraction. En Braunwald E: Heart Disease (8ª edición). Saunders Elsevier, Philadelphia, 2008 (Revisión).